Guangdong, where the non-woven fabric industry is developed, has independently researched and developed disposable medical protective clothing, and obtained provincial drug regulatory approval, becoming one of the top enterprises in the industry in China. However, raw materials for medical non-woven fabrics still depend on imports, and the inability to produce raw materials independently has brought some difficulties to the prevention and treatment of SARS in China. In the first half of 2003 alone, domestic non-woven spunlace and spunbond capacity increased by more than 40%. SARS has unprecedentedly promoted the development of various medical protective products for isolation clothing and masks, and successively introduced meltblown nonwovens and spunbond, meltblown composite nonwovens SMS, SMMS isolation clothing and masks, spunbond nonwovens and TPU moisture permeability Membrane, and various microporous breathable membrane composite products. In the year of SARS, the total consumption of medical non-woven fabrics increased by 13% over the previous year.
